Literature DB >> 23372224

Authors' reply.

Caroline T Nguyen1, Siba P Raychaudhuri.   

Abstract

Entities:  

Year:  2013        PMID: 23372224      PMCID: PMC3555385     

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


× No keyword cloud information.
Sir, In response to our report on Scedosporium apiospermum sinusitis in a patient following prolonged anti-TNFα therapy,[1] Dr. Monika Matlani has brought to our notice about a case of Scedosporium prolificans osteomyelitis in an immunocompetent child. Scedosporium infection has been reported in both immunocompetent and immunocompromised subjects. However, Scedosporium is mostly an opportunistic fungus. In recent years, an increasing number of cases of human disease with S. apiospermum have been reported, probably due to widespread use of corticosteroids, immunosuppressants, antineoplastics and broad-spectrum antibiotics. Thus, it is essential for dermatologists to be aware of clinical presentations and diagnosis of Scedosporium infection. Cutaneous manifestations of Scedosporium infection are protean. In most cases, inoculation of spores in the cutaneous and subcutaneous tissues is due to penetrating trauma or surgery. Scedosporium spp. infections can present as papules, erythematous plaques, folliculitis, necrotic papules, cutaneous ulcers, nodules, subcutaneous abscesses, and ulcers in a sporotrichoid (lymphangitic) pattern, ecchymosis, and hemorrhagic bullae.[2-4] Thus, the cutaneous manifestations are nonspecific and can be misleading in respect to the underlying disease. In appropriate clinical scenario, specifically in immunocompromised patients, physicians need to be suspicious for Scedosporium and other opportunistic infections. On occasions, a specific diagnosis of Scedosporium infection may require repeated biopsies, specific fungal staining, and fungal culture.
  4 in total

1.  Cutaneous Scedosporium apiospermum infection in an immunocompromised patient.

Authors:  C P Bower; J D Oxley; C K Campbell; C B Archer
Journal:  J Clin Pathol       Date:  1999-11       Impact factor: 3.411

Review 2.  Scedosporium apiospermum skin infection: a case report and review of the literature.

Authors:  T Miyamoto; R Sasaoka; M Kawaguchi; S Ishioka; T Inoue; N Yamada; M Mihara
Journal:  J Am Acad Dermatol       Date:  1998-09       Impact factor: 11.527

Review 3.  Cutaneous Scedosporium apiospermum infection in an immunocompromised patient and a review of the literature.

Authors:  Takeshi Uenotsuchi; Yoichi Moroi; Kazunori Urabe; Gaku Tsuji; Tetsuya Koga; Tetsuo Matsuda; Masutaka Furue
Journal:  Acta Derm Venereol       Date:  2005       Impact factor: 4.437

4.  SCEDOSPORIUM INFECTION IN A PATIENT WITH ANTI-TNFα THERAPY.

Authors:  Caroline T Nguyen; Siba P Raychaudhuri
Journal:  Indian J Dermatol       Date:  2011-01       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.